Your browser doesn't support javascript.
loading
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker.
Fäldt Beding, Anna; Larsson, Peter; Helou, Khalil; Einbeigi, Zakaria; Parris, Toshima Z.
Affiliation
  • Fäldt Beding A; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. anna.faldt.beding@gu.se.
  • Larsson P; Department of Oncology, Southern Älvsborg Hospital, Borås, Sweden. anna.faldt.beding@gu.se.
  • Helou K; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Einbeigi Z; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Parris TZ; Department of Oncology, Southern Älvsborg Hospital, Borås, Sweden.
BMC Cancer ; 22(1): 322, 2022 Mar 25.
Article in En | MEDLINE | ID: mdl-35331169
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survivin / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Suecia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Survivin / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Suecia